VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 96 filers reported holding VERVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,445 | -19.1% | 3,201 | +14.4% | 0.00% | -33.3% |
| Q2 2023 | $52,463 | +30.0% | 2,798 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $40,347 | -25.5% | 2,798 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $54,141 | -43.7% | 2,798 | 0.0% | 0.00% | -60.0% |
| Q3 2022 | $96,111 | +156.4% | 2,798 | +14.1% | 0.01% | +150.0% |
| Q2 2022 | $37,482 | -33.0% | 2,453 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $55,977 | -65.5% | 2,453 | -44.2% | 0.00% | 0.0% |
| Q4 2021 | $162,191 | -21.6% | 4,399 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $206,753 | – | 4,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |